The Hormones in Dosage Except Contraceptives and Antibiotics market in Oman in 2023 reached a per capita value of 7.79 USD. Over the past decade, the market showed fluctuations, peaking in 2021 at 7.96 USD. The year-on-year growth analysis from 2022 to 2023 reveals a slight uptick, indicating the market's resilience. From 2019 to 2023, the compound annual growth rate (CAGR) averaged at a moderate pace, reflecting steady demand in the sector despite economic challenges and health crises.

Future trends to watch include:

Advancements in hormone therapies and precision medicine which may influence market growth.
Potential regulatory changes and healthcare reforms in Oman impacting hormone drug availability and market dynamics.
Shifts in population demographics and lifestyle diseases leading to increased hormone therapy demand.